Purdue David Ryan bought ABBV
February 18, 2026 · Form 4 insider transaction
Purdue David Ryan bought 4,875 shares of AbbVie Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,875
Price
$0.00
Total value
N/A
InsiderPurdue David Ryan
RoleOfficer
CompanyAbbVie Inc. (ABBV)
SecurityOption (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after4,875
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 1,625 on February 18, 2027, 1,625 on February 18, 2028, and 1,625 on February 18, 2029.